Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

466 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Standard ECG for differential diagnosis between Anderson-Fabry disease and hypertrophic cardiomyopathy.
Vitale G, Ditaranto R, Graziani F, Tanini I, Camporeale A, Lillo R, Rubino M, Panaioli E, Di Nicola F, Ferrara V, Zanoni R, Caponetti AG, Pasquale F, Graziosi M, Berardini A, Ziacchi M, Biffi M, Santostefano M, Liguori R, Taglieri N, Nardi E, Linhart A, Olivotto I, Rapezzi C, Biagini E. Vitale G, et al. Among authors: rubino m. Heart. 2022 Jan;108(1):54-60. doi: 10.1136/heartjnl-2020-318271. Epub 2021 Feb 9. Heart. 2022. PMID: 33563631
Severe hypertrophic cardiomyopathy in a patient with atypical Anderson-Fabry disease.
Masarone D, Duro G, Dellegrottaglie S, Colomba P, Rubino M, Cirillo A, Pisani A, Caiazza M, Elliott PM, Calabrò P, Pacileo G, Limongelli G. Masarone D, et al. Among authors: rubino m. Future Cardiol. 2017 Nov;13(6):521-527. doi: 10.2217/fca-2017-0011. Epub 2017 Sep 22. Future Cardiol. 2017. PMID: 28936893
Prevalence and clinical significance of red flags in patients with hypertrophic cardiomyopathy.
Limongelli G, Monda E, Tramonte S, Gragnano F, Masarone D, Frisso G, Esposito A, Gravino R, Ammendola E, Salerno G, Rubino M, Caiazza M, Russo M, Calabrò P, Elliott PM, Pacileo G. Limongelli G, et al. Among authors: rubino m. Int J Cardiol. 2020 Jan 15;299:186-191. doi: 10.1016/j.ijcard.2019.06.073. Epub 2019 Jul 4. Int J Cardiol. 2020. PMID: 31303393
Combined Effect of Mediterranean Diet and Aerobic Exercise on Weight Loss and Clinical Status in Obese Symptomatic Patients with Hypertrophic Cardiomyopathy.
Limongelli G, Monda E, D'Aponte A, Caiazza M, Rubino M, Esposito A, Palmiero G, Moscarella E, Messina G, Calabro' P, Scudiero O, Pacileo G, Monda M, Bossone E, Day SM, Olivotto I. Limongelli G, et al. Among authors: rubino m. Heart Fail Clin. 2021 Apr;17(2):303-313. doi: 10.1016/j.hfc.2021.01.003. Epub 2021 Feb 10. Heart Fail Clin. 2021. PMID: 33673954 Review.
Clinical presentation and long-term outcomes of infantile hypertrophic cardiomyopathy: a European multicentre study.
Norrish G, Kolt G, Cervi E, Field E, Dady K, Ziółkowska L, Olivotto I, Favilli S, Passantino S, Limongelli G, Caiazza M, Rubino M, Baban A, Drago F, Mcleod K, Ilina M, McGowan R, Stuart G, Bhole V, Uzun O, Wong A, Lazarou L, Brown E, Daubeney PEF, Lota A, Delle Donne G, Linter K, Mathur S, Bharucha T, Adwani S, Searle J, Popoiu A, Jones CB, Reinhardt Z, Kaski JP. Norrish G, et al. Among authors: rubino m. ESC Heart Fail. 2021 Dec;8(6):5057-5067. doi: 10.1002/ehf2.13573. Epub 2021 Sep 6. ESC Heart Fail. 2021. PMID: 34486247 Free PMC article.
Diagnosis and Management of Cardiovascular Involvement in Fabry Disease.
Rubino M, Monda E, Lioncino M, Caiazza M, Palmiero G, Dongiglio F, Fusco A, Cirillo A, Cesaro A, Capodicasa L, Mazzella M, Chiosi F, Orabona P, Bossone E, Calabrò P, Pisani A, Germain DP, Biagini E, Pieroni M, Limongelli G. Rubino M, et al. Heart Fail Clin. 2022 Jan;18(1):39-49. doi: 10.1016/j.hfc.2021.07.005. Epub 2021 Oct 25. Heart Fail Clin. 2022. PMID: 34776082 Review.
Natural history of left ventricular hypertrophy in infants of diabetic mothers.
Monda E, Verrillo F, Altobelli I, Lioncino M, Caiazza M, Rubino M, Cirillo A, Fusco A, Esposito A, Di Fraia F, Pacileo R, Gragnano F, Passariello A, Calabrò P, Russo MG, Limongelli G. Monda E, et al. Among authors: rubino m. Int J Cardiol. 2022 Mar 1;350:77-82. doi: 10.1016/j.ijcard.2021.12.043. Epub 2021 Dec 27. Int J Cardiol. 2022. PMID: 34968628
Association between common cardiovascular risk factors and clinical phenotype in patients with hypertrophic cardiomyopathy from the European Society of Cardiology (ESC) EurObservational Research Programme (EORP) Cardiomyopathy/Myocarditis registry.
Lopes LR, Losi MA, Sheikh N, Laroche C, Charron P, Gimeno J, Kaski JP, Maggioni AP, Tavazzi L, Arbustini E, Brito D, Celutkiene J, Hagege A, Linhart A, Mogensen J, Garcia-Pinilla JM, Ripoll-Vera T, Seggewiss H, Villacorta E, Caforio A, Elliott PM; Cardiomyopathy Registry Investigators Group. Lopes LR, et al. Eur Heart J Qual Care Clin Outcomes. 2022 Dec 13;9(1):42-53. doi: 10.1093/ehjqcco/qcac006. Eur Heart J Qual Care Clin Outcomes. 2022. PMID: 35138368 Free PMC article.
Bisoprolol for treatment of symptomatic patients with obstructive hypertrophic cardiomyopathy. The BASIC (bisoprolol AS therapy in hypertrophic cardiomyopathy) study.
Monda E, Lioncino M, Palmiero G, Franco F, Rubino M, Cirillo A, Verrillo F, Fusco A, Caiazza M, Mazzella M, Moscarella E, Dongiglio F, Sepe J, Pacileo G, Calabrò P, Limongelli G. Monda E, et al. Among authors: rubino m. Int J Cardiol. 2022 May 1;354:22-28. doi: 10.1016/j.ijcard.2022.03.013. Epub 2022 Mar 10. Int J Cardiol. 2022. PMID: 35278578
466 results